Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Violetta Marafioti"'
Autor:
Rossella Iula, Danilo De Novellis, Fabio Trastulli, Roberta Della Pepa, Raffaele Fontana, Angela Carobene, Maria Di Perna, Alessandro D’Ambrosio, Martina Romano, Aldo Leone, Laura De Fazio, Alfonso Fiumarella, Giuseppe Gaeta, Violetta Marafioti, Serafina Barbato, Salvatore Palmieri, Stefano Rocco, Bianca Serio, Catello Califano, Fabrizio Pane, Felicetto Ferrara, Valentina Giudice, Carmine Selleri, Lucio Catalano
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Belantamab-mafodotin is an innovative and selective treatment for multi-refractory/relapsed multiple myeloma (MM) patients; however, available real-life experiences on efficacy and safety are limited. In this real-world multicentric retrospective stu
Externí odkaz:
https://doaj.org/article/03cd58faa7954daf802d2791e97b5698
Autor:
Maria Gabriella Rascato, Massimo Mascolo, Roberta Della Pepa, Marco Picardi, Alessandro D’Ambrosio, Novella Pugliese, Daniela Russo, Giuseppe Delle Cave, Aldo Leone, Claudia Giordano, Fabrizio Pane, Violetta Marafioti, Francesco Muriano
Publikováno v:
Cancers
Volume 13
Issue 8
Cancers, Vol 13, Iss 1760, p 1760 (2021)
Volume 13
Issue 8
Cancers, Vol 13, Iss 1760, p 1760 (2021)
Background: Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare variant of HL that accounts for 5% of all HL cases. The expression of CD20 on neoplastic lymphocytes provides a suitable target for novel treatments based on Rituximab. Due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48db1eaaf396f2463d64709e92551e36
http://hdl.handle.net/11588/857077
http://hdl.handle.net/11588/857077
